title: Understanding EMPA-REG OUTCOME.
authors.affiliation: Division of Endocrinology, St Michael's Hospital, Toronto, ON M5B 1W8, Canada. Electronic address: richard.gilbert@utoronto.ca.
authors.forename: Richard E
authors.initials: RE
authors.lastname: Gilbert
authors.affiliation: Division of Cardiology, St Michael's Hospital, Toronto, ON M5B 1W8, Canada.
authors.forename: Kim A
authors.initials: KA
authors.lastname: Connelly
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005960:Glucosides / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents